Quantum-Si (NASDAQ:QSI) Issues Earnings Results

Quantum-Si (NASDAQ:QSI) announced its quarterly earnings data on Tuesday. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.03, reports. The company had revenue of $0.79 million during the quarter, compared to analysts’ expectations of $1.06 million. Quantum-Si had a negative net margin of 3,968.84% and a negative return on equity of 36.96%.

Quantum-Si Stock Down 1.5 %

Shares of NASDAQ QSI opened at $0.78 on Friday. Quantum-Si has a 1-year low of $0.70 and a 1-year high of $2.43. The company has a fifty day moving average price of $0.86 and a 200 day moving average price of $1.11.

Hedge Funds Weigh In On Quantum-Si

Hedge funds have recently bought and sold shares of the business. Bleakley Financial Group LLC acquired a new position in shares of Quantum-Si in the 1st quarter valued at about $28,000. Vanguard Group Inc. increased its stake in shares of Quantum-Si by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after purchasing an additional 82,463 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Quantum-Si by 11.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock worth $118,000 after purchasing an additional 5,945 shares during the period. Public Employees Retirement System of Ohio bought a new stake in Quantum-Si during the 1st quarter worth approximately $27,000. Finally, Jacobs Levy Equity Management Inc. bought a new stake in shares of Quantum-Si during the 1st quarter worth $998,000. 39.90% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on QSI. Canaccord Genuity Group decreased their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday. HC Wainwright reissued a “buy” rating and issued a $4.00 price target on shares of Quantum-Si in a report on Wednesday.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.